Leukemia

Study: New Mapping Method Improves Detection of Leukemia Abnormalities

Research shows optical genome mapping identifies genomic changes in nearly 98% of T-cell acute lymphoblastic leukemia cases compared to 55% with traditional analysis.

Leukemia

New Panel-Agnostic Automated AML Diagnosis Solution Unveiled

A new diagnostic classification module for AHEAD Medicine's Cyto-Copilot platform enhances AML versus non-neoplastic classification.

Leukemia

Panel Detects BCR-ABL1 Oncogene Isoform Co-Expression in CML Patient

The HemeScreen BCR-ABL1 Panel enabled Precipio’s clinical lab to detect a co-expression of both p190 and p210 isoforms in this patient, leading to more informed care decisions.

Powerful New Tools to Diagnosis Blood Cancers in Development

Sep 28, 2022 | Leukemia, Lymphoma

Scientists are using new technology to improve the diagnosis and treatment of blood cancers, which affect 1.24 million people globally.

Simple Blood Test Predicts Neurotoxic Complications of CAR-T Cell Therapy

Sep 2, 2022 | Leukemia, Lymphoma

CAR-T cell therapy has revolutionized the treatment of several cancers, using modified T cells to target types of leukemia & lymphoma.

Researchers Discover Cells That Can Transform into Leukemia

Jun 28, 2022 | Leukemia

Everyone has a small number of an unusual thymocyte cell, which can become a form of leukemia called T-cell acute lymphoblastic leukemia.

NIH Awards Grant for Autofluorescence-Free Cytometry Development

Mar 28, 2022 | Flow Cytometry Instruments, Leukemia

Kinetic River has been awarded a Phase II SBIR grant for the development of an autofluorescence-free flow cytometry platform.

Acute Myeloid Leukemia Subtypes Help Treatment

Mar 8, 2022 | Leukemia

To better treat patients with acute myeloid leukemia, researchers discovered a novel subtype of the cancer via proteome and genetic analysis.

Improved Monitor of Cancer Recurrence in Leukemia Patients Through New Protocol

Feb 8, 2022 | Leukemia

Researchers have developed a new protocol for monitoring acute lymphoblastic leukemia to inform more effective treatment strategies.

BioFluidica to Commericalize LiquidScan Biopsy System

Sep 21, 2021 | Leukemia, Microbiology Instruments, Prenatal Testing

BioFluidica, a privately held biotechnology company, plans to commercialize its LiquidScan Automated Liquid Biopsy System.

Qlucore Awarded Grant to Aid Clinical Diagnostics of Cancer

Dec 15, 2020 | Leukemia, Middleware & Software, Unknown Origin & Other Cancer Types

The grant will allow Qlucore to expand Qlucore Diagnostics software with a focus on RNA-profiling of glioma and acute leukemia.

Study Demonstrates New Tool for Rapid Evaluation of Acute Leukemia Patients

Oct 19, 2020 | Hematology Instrumentation, Leukemia

PixCell’s HemoScreen may be used to monitor pathological blood samples, improving treatment process for hematological patients.

Multicancer Blood Test, Combined with Imaging, Shows Promise as Screen for Cancer

May 4, 2020 | Breast, Cancer, Cervical (HPV), Leukemia, Lung Cancer, Lymphoma, Melanoma, Molecular Diagnostics, Pancreatic, Prostate, Unknown Origin & Other Cancer Types

The blood test followed by PET-CT imaging was 99.6% specific for cancer.

Study Offers Promise for Early Detection of Infections among Childhood Leukemia Patients

Apr 21, 2020 | Cancer, Cardiovascular, Computing Systems, Gastrointestinal Infections, Information Technology, Leukemia, Middleware & Software, Molecular Diagnostics

A noninvasive blood test may provide a ‘crystal ball’ for early detection of infections, leading to increased cure rates among pediatric leukemia patients.